Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The exosome–cell surface uptake machinery refers to the collective group of proteins and lipids on the recipient cell membrane responsible for the binding and internalisation of exosomes and other extracellular vesicles (EVs). This machinery is not a single molecule but a complex system involving heparan sulfate proteoglycans (HSPGs), tetraspanins (such as CD81 and CD63), integrins, and various endocytic proteins like clathrin and dynamin (McKelvey et al., 2015, J Circ Biomark). These components facilitate the transfer of bioactive cargo, including proteins, lipids, and RNAs, which can alter the phenotype of the recipient cell. In pathological contexts, such as cancer, this machinery is often hijacked to promote pre-metastatic niche formation, drug resistance, and immune evasion (Costa-Silva et al., 2015, Nature). Therapeutic strategies targeting this machinery aim to block the uptake of pathogenic exosomes using small molecule inhibitors of endocytosis or competitive binders like heparin to prevent disease progression (Mulcahy et al., 2014, J Extracell Vesicles).
Inhibition of heparan sulfate proteoglycan binding, inhibition of dynamin-dependent endocytosis, blockade of clathrin-mediated endocytosis, or inhibition of macropinocytosis and actin polymerization.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exosome–cell surface uptake machinery (ECSUM).